uniQure BV (QURE) PT Lowered to $14 at Stifel on FDA uncertainty
Tweet Send to a Friend
Stifel analyst Paul Matteis lowered the price target on uniQure BV (NASDAQ: QURE) to $14.00 (from $40.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
